Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Muylle

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Revue Medicale De Bruxelles|May 20, 2017
[Tuberculosis in general practice in Belgium : What's new?]B Legius, V Ninane, I Muylle
Revue Des Maladies Respiratoires|June 30, 2012
[EBUS: a long and quiet river]I Muylle, I De Meulder, M Bruyneel, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 14, 2012
Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosisM C Payen, S De Wit, C Martin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 4, 2018
Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free casesM C Payen, I Muylle, O Vandenberg, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 29, 2015
Beyond multidrug-resistant tuberculosis in Europe: a TBNET studyG Günther, F van Leth, N Altet, et al.
IJTLD Open|February 17, 2025
Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in EuropeO Kirakosyan, M Reimann, A B Andersen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Revue Medicale De Bruxelles|May 20, 2017
[Tuberculosis in general practice in Belgium : What's new?]B Legius, V Ninane, I Muylle
Revue Des Maladies Respiratoires|June 30, 2012
[EBUS: a long and quiet river]I Muylle, I De Meulder, M Bruyneel, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 14, 2012
Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosisM C Payen, S De Wit, C Martin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 4, 2018
Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free casesM C Payen, I Muylle, O Vandenberg, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 29, 2015
Beyond multidrug-resistant tuberculosis in Europe: a TBNET studyG Günther, F van Leth, N Altet, et al.
IJTLD Open|February 17, 2025
Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in EuropeO Kirakosyan, M Reimann, A B Andersen, et al.
Pageof 1